...
首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >Membrane topology of gp41 and amyloid precursor protein: interfering transmembrane interactions as potential targets for HIV and Alzheimer treatment.
【24h】

Membrane topology of gp41 and amyloid precursor protein: interfering transmembrane interactions as potential targets for HIV and Alzheimer treatment.

机译:gp41和淀粉样蛋白前体蛋白的膜拓扑:干扰跨膜相互作用作为HIV和阿尔茨海默病治疗的潜在目标。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The amyloid precursor protein (APP), that plays a critical role in the development of senile plaques in Alzheimer disease (AD), and the gp41 envelope protein of the human immunodeficiency virus (HIV), the causative agent of the acquired immunodeficiency syndrome (AIDS), are single-spanning type-1 transmembrane (TM) glycoproteins with the ability to form homo-oligomers. In this review we describe similarities, both in structural terms and sequence determinants of their TM and juxtamembrane regions. The TM domains are essential not only for anchoring the proteins in membranes but also have functional roles. Both TM segments contain GxxxG motifs that drive TM associations within the lipid bilayer. They also each possess similar sequence motifs, positioned at the membrane interface preceding their TM domains. These domains are known as cholesterol recognition/interaction amino acid consensus (CRAC) motif in gp41 and CRAC-like motif in APP. Moreover, in the cytoplasmic domain of both proteins other alpha-helical membranotropic regions with functional implications have been identified. Recent drug developments targeting both diseases are reviewed and the potential use of TM interaction modulators as therapeutic targets is discussed.
机译:淀粉样蛋白前体蛋白(APP)在阿尔茨海默病(AD)老年斑的形成中起关键作用,而人类免疫缺陷病毒(HIV)的gp41包膜蛋白是获得性免疫缺陷综合征(AIDS)的病原体)是具有形成同源寡聚体能力的单跨度1型跨膜(TM)糖蛋白。在这篇综述中,我们描述了其TM和近膜区的结构术语和序列决定子的相似性。 TM结构域不仅对于将蛋白锚定在膜中至关重要,而且具有功能性作用。这两个TM片段均含有GxxxG基序,这些基序驱动脂质双层内的TM缔合。它们还各自具有相似的序列基序,位于其TM结构域之前的膜界面上。这些域在gp41中称为胆固醇识别/相互作用氨基酸共有(CRAC)主题,在APP中称为CRAC-like主题。此外,在两种蛋白质的胞质结构域中,已经确定了具有功能意义的其他α-螺旋膜区域。综述了针对这两种疾病的最新药物开发,并讨论了TM相互作用调节剂作为治疗靶标的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号